Abstracts Archive - Page 2316 of 2425 - ACR Meeting Abstracts

Abstract Number: 1581 • 2012 ACR/ARHP Annual Meeting
The Association Between Symptoms, Pain Coping Strategies, and Physical Activity Among People with Symptomatic Knee and Hip Osteoarthritis
Susan L. Murphy¹, Anna Kratz², David A. Williams³ and Michael E. Geisser², ¹Physical Medicine & Rehabilitation, University of Michigan, Ann Arbor, MI, ²Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, ³Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI
Background/Purpose: Effective use of coping strategies by people with chronic pain conditions is associated with better functioning and adjustment to chronic disease. Although the effects…
Abstract Number: 1582 • 2012 ACR/ARHP Annual Meeting
Long Term Costs and Cost-Effectiveness of an Integrated Rehabilitation Programme for Chronic Knee Pain
Mike Hurley¹ and Dr Nicola E. Walsh², ¹School of Rehabilitation Sciences, St George's University of London, London, United Kingdom, ²Allied Health Professions, University of the West of England Bristol, Bristol, United Kingdom
Background/Purpose: Management of chronic knee pain incurs enormous direct and indirect healthcare costs. Enabling Self-management and Coping with Arthritic knee Pain through Exercise (ESCAPE-knee pain)…
Abstract Number: 1583 • 2012 ACR/ARHP Annual Meeting
Therapist and Patient Perspectives On Exercise Adherence: Are We On the Same Page?
Jill R. Blitz¹, Talitha Cox² and Amber Richards³, ¹Rehab Services, Children's Hospital Los Angeles, Los Angeles, CA, ²Rehabilitation Services, Children's Hospital of Los Angeles, Los Angeles, CA, ³Rehab Services, Children's Hospital, Los Angeles California, Los Angeles, CA
Background/Purpose: Exercise is essential to the health and function of children with chronic diseases. Patient adherence to home exercise programs has long been an obstacle…
Abstract Number: 1584 • 2012 ACR/ARHP Annual Meeting
Validity of the Nurses Health Study II Physical Activity Questionnaire (NHSPAQ) in Estimating Physical Activity in Adults with Rheumatoid Arthritis (RA)
Maura D. Iversen¹, Thomas Quinn² and Michelle A. Frits³, ¹Department of Physical Therapy, Movement & Rehabilitation Sciences, Northeastern University, Boston, MA, ²Biology, Northeastern University, Boston, MA, ³Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: An accurate assessment of physical activity (PA) is critical to manage rheumatoid arthritis (RA). Accelerometry is an objective measure of PA but is not…
Abstract Number: 1585 • 2012 ACR/ARHP Annual Meeting
Physical Activity and Timing of Discharge From Physical Therapy Following Total Knee Replacement
Carol A. Oatis¹, Wenjun Li², Milagros Rosal³, David Ayers² and Patricia D. Franklin², ¹Physical Therapy, Arcadia University, Glenside, PA, ²Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ³Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: In 2009 over 620,000 total knee replacement (TKR) surgeries were performed. That number is expected to increase to 3.5 million annually by 2030. Post-operative…
Abstract Number: 1586 • 2012 ACR/ARHP Annual Meeting
Resistance Exercise Training for Fibromyalgia: A Systematic Review
Angela J. Busch¹, Sandra Webber², Rachel Richards³, Julia Bidonde⁴, Candice Schachter¹, Laurel Schafer⁵, Adrienne Danyliw⁶, Anuradha Sawant⁷, Vanina Dal Bello Haas⁸ and Tamara Rader⁹, ¹School of Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada, ²University of Saskatchewan, Saskatoon, SK, Canada, ³North Shore Sports Medicine Clinic, North Vancouver, BC, Canada, ⁴Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada, ⁵Central Avenue Physiotherapy, Swift Current, SK, Canada, ⁶Health Quality Council, Saskatoon, SK, Canada, ⁷Renal/Clinical neurosciences program, London Health Sciences Center, ON, Canada, ⁸School of Physical Therapy, McMaster University, Hamilton, ON, Canada, ⁹University of Ottawa, Ottawa, ON, Canada
Background/Purpose: This systematic review investigated the effects of resistance exercise training on signs and symptoms, and physical fitness in people with fibromyalgia. Fibromyalgia, a condition…
Abstract Number: 1587 • 2012 ACR/ARHP Annual Meeting
Despite Low Disease Activity Patients with Poly- and Dermatomyositis Perceive Activity Limitation, Reduced Grip Force and Quality of Life Longitudinally
Malin Regardt¹, Marie-Louise Schult², Ingrid E. Lundberg³ and Elisabet MB Welin Henriksson⁴, ¹Department of Occupational Therapy, Department of Neurobiology, Care Sciences and Society, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ²Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet., Stockholm, Sweden, ³Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, ⁴Medicine, Karolinska Institutet Rheum, Stockholm, Sweden
Background/Purpose: Polymyositis (PM) and dermatomyositis (DM) are characterized by proximal muscle weakness. A recent study has shown that patients with PM and DM have reduced…
Abstract Number: 1588 • 2012 ACR/ARHP Annual Meeting
Relationship Over Time Between Beliefs, Motivation, and Worries about Physical Activity and Physical Activity Participation in Persons with Knee Osteoarthritis
Linda S. Ehrlich-Jones¹, Jungwha Lee², Dorothy D. Dunlop³, Pamela A. Semanik², Min-Woong Sohn⁴, Jing Song³ and Rowland W. Chang³, ¹Research CROR, Rehabilitation Institute Chicago, Chicago, IL, ²Northwestern University, Chicago, IL, ³Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Institute for Public Health and Medicine, Northwestern University, Chicago, IL
Background/Purpose: To determine the relationship over time between beliefs, motivation, and worries about physical activity and physical activity participation in persons with knee osteoarthritis…
Abstract Number: 1589 • 2012 ACR/ARHP Annual Meeting
Obesity and Rehabilitation Outcomes After Lower Extremity Arthroplasty
Soham Al Snih, Amol Karmarkar, Timothy A. Reistetter, Jinhyung Lee, Amit Kumar, James E. Graham and Kenneth J. Ottenbacher, University of Texas Medical Branch, Galveston, TX
Background/Purpose: To examine the effect of obesity on inpatient rehabilitation outcomes after lower extremity arthroplasty procedures (hip and knee) among Medicare Beneficiaries aged 65 years…
Abstract Number: 1590 • 2012 ACR/ARHP Annual Meeting
Post-Operative Rehabilitation Provides Unmet Need for Better Patient Support and Advice Following Lumbar Spinal Fusion
Michael V. Hurley¹, James Greenwood² and Dr Nicola E. Walsh³, ¹School of Rehabilitation Sciences, St George's University of London and Kingston University, London, United Kingdom, ²Physiotherapy, University College Hospital London, London, United Kingdom, ³Allied Health Professions, University of the West of England Bristol, Bristol, United Kingdom
Background/Purpose: In the absence of evidence-based post-operative rehabilitation, following fusion surgery for severe persistent low back pain, people receive advice to rest for 3 months…
Abstract Number: 1591 • 2012 ACR/ARHP Annual Meeting
Efficacy of Neoprene Wrist Supports for Patients with Rheumatoid Arthritis
Kinue Matsuo¹, Koji Tateishi², Natsuko Nakagawa² and Yasushi Miura³, ¹Dept. of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, ²Dept. of Orthopaedic Surgery, Konan Kakogawa Hospital, Kakogawa, Japan, ³Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan
Background/Purpose: Wrist joints are frequently damaged by rheumatoid arthritis (RA). Wrist supports are often used to reduce pain and strain on wrists when patients with…
Abstract Number: 1592 • 2012 ACR/ARHP Annual Meeting
A Novel Approach to the Early Detection of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease: The Implementation of an Advanced Practice Physiotherapist Led Screening Program
Laura A. Passalent¹, Rebecca Morton², Khalid A. Alnaqbi³, Nigil Haroon⁴, Stephen Wolman⁵, Mark Silverberg⁶, A. Hillary Steinhart⁷ and Robert D. Inman⁸, ¹Allied Health, Allied Health, Toronto Western Hospital, Toronto, ON, Canada, ²Allied Health/Rheumatology, University Health Network- Toronto Western Hospital, Toronto, ON, Canada, ³Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ⁴Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁵Gastroenterology, Toronto General Hospital, Toronto, ON, Canada, ⁶Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Group,, Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada, ⁷Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada, ⁸Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada
Background/Purpose: The prevalence of SpA in patients with inflammatory bowel disease (IBD) ranges from 3.1 - 10%, compared to
Abstract Number: 1593 • 2012 ACR/ARHP Annual Meeting
The Risk of Lymphoma in Patients Receiving Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register – Rheumatoid Arthritis
Louise K. Mercer¹, Mark Lunt², Audrey S. Low³, James B. Galloway², Kath Watson⁴, William G. Dixon⁵, BSRBR Control Centre Consortium², Deborah P. Symmons³, Kimme L. Hyrich⁶ and On behalf of the BSRBR⁷, ¹Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, ²Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, ³Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, ⁴Arthritis Research UK Epidemiology Unit, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, ⁵The University of Manchester, Manchester, United Kingdom, ⁶Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, Manchester, United Kingdom, ⁷British Society for Rheumatology, London, United Kingdom
Background/Purpose: The risk of lymphoma is increased in people with RA compared to the general population and is greatest in severe RA. Anti-TNF therapy is…
Abstract Number: 1594 • 2012 ACR/ARHP Annual Meeting
Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis
L. Heimans¹, K.V.C. Wevers-de Boer¹, K. Visser¹, H.K. Ronday², M. van Oosterhout³, J. H. L. M. Van Groenendael⁴, A.J. Peeters⁵, G. Steup-Beekman⁶, G. Collee⁷, P.B.J Sonnaville⁸, B.A. Grillet⁹, Tom Huizinga¹ and C.F. Allaart¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, Haga Hospital, The Hague, Netherlands, ³Rheumatology, Groene Hart Hospital, Gouda, Netherlands, ⁴Franciscus Hospital, Roosendaal, Netherlands, ⁵Rheumatology, Reinier de Graaf Gasthuis, Delft, Netherlands, ⁶Rheumatology, Bronovo Hospital, Netherlands, ⁷MCH, The Hague, Netherlands, ⁸Admiraal de Ruyter Ziekenhuis, Goes, Netherlands, ⁹Department of Rheumatology, Zorgsaam Hospital, Terneuzen, Netherlands
Background/Purpose: To evaluate the 1 year clinical and radiological outcomes of remission steered therapy in early arthritis patients treated aiming at remission (DAS
Abstract Number: 1595 • 2012 ACR/ARHP Annual Meeting
Genome-Wide Association Study to High -Throughput Cell-Based Phenotypic Screen Identifies Novel Chemical Inhibitors of CD40 Signaling
Gang Li¹, Dorothee Diogo², Di Wu¹, Jim Spoonamore³, Rheumatoid Arthritis Consortium International (RACI)⁴, Eli Stahl⁵, Nicola Tolliday³ and Robert M. Plenge⁶, ¹Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, ³Broad Institute, Cambridge, MA, ⁴Boston, ⁵Brigham and Women's Hospital, ⁶Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Deriving therapeutic targets from human genetics linked with biological alterations of risk alleles may provide a more successful approach to drug development than traditional…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].